Related Experiment Video

Updated: May 31, 2026

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

Mitochondrial drug targets in cell death and cancer

Gustavo Ferrín1, Clara I Linares, Jordi Muntané

  • 1Liver Research Unit, Instituto Maimónides para la Investigación Biomédica de Córdoba, Reina Sofia University Hospital, Córdoba, Spain.

Current Pharmaceutical Design
|July 2, 2011
PubMed

Insights

Mitochondria play a crucial role in cancer cell survival and death. This review explores therapeutic strategies targeting mitochondria to induce apoptosis and combat cancer growth.

Area of Science:

  • Mitochondrial biology
  • Cancer research
  • Apoptosis induction

Background:

  • Mitochondria are vital for tumor cell physiology, growth, and survival.
  • Cancer cells often evade cell death pathways, highlighting mitochondria as potential targets for therapy.
  • Disruptions in mitochondrial function are common in cancer.

Purpose of the Study:

  • To review experimental and therapeutic strategies targeting mitochondria in cancer.
  • To explore the use of mitochondria as mediators of apoptosis for cancer treatment.
  • To categorize drugs based on their direct mitochondrial targeting or their role in apoptosis induction.

Main Methods:

  • Review of existing literature on mitochondria-targeted cancer therapies.
  • Categorization of therapeutic strategies based on their mechanism of action.
  • Analysis of drugs affecting glycolysis, beta-oxidation, and electron transport chain.
  • Examination of agents modulating mitochondrial permeability and Bcl-2/IAP family proteins.
  • Investigation of drugs inducing apoptosis via the intrinsic pathway, ROS generation, or modulation of mitochondrial proteins.

Main Results:

  • Mitochondria-targeted therapies can directly impact cancer cell metabolism and survival.
  • Strategies utilizing mitochondria as apoptosis mediators can overcome cancer cell resistance.
  • Drugs targeting glycolysis, beta-oxidation, and the electron transport chain offer direct mitochondrial intervention.
  • Modulation of mitochondrial permeability and Bcl-2/IAP proteins provides additional therapeutic avenues.
  • Induction of apoptosis through ROS generation or specific mitochondrial proteins is a key therapeutic approach.

Conclusions:

  • Mitochondria represent a promising target for novel cancer therapeutics.
  • Targeting mitochondria directly or using them to mediate apoptosis can overcome cancer cell survival mechanisms.
  • A deeper understanding of mitochondrial pathways in cancer can lead to more effective treatments.
  • Combined strategies involving metabolic targeting and apoptosis induction may enhance therapeutic outcomes.

More Related Videos

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...